Pabolizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pabolizumab, covering 2022-03-24 to 2022-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma [Phase 2]